These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3519026)

  • 41. Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity.
    McNally PG; Baker F; Mistry N; Walls J; Feehally J
    Clin Sci (Lond); 1990 Sep; 79(3):259-66. PubMed ID: 2169375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental cyclosporin hypertension: characterization of the rat model.
    Lustig S; Stern N; Golub MS; Eggena P; Barrett J; Lee DB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):950-1. PubMed ID: 2705265
    [No Abstract]   [Full Text] [Related]  

  • 43. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclosporine and experimental renal ischemic injury.
    Chow SS; Thorner P; Baumal R; Wilson DR
    Transplantation; 1986 Feb; 41(2):152-6. PubMed ID: 3946012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients.
    Textor SC; Forman SJ; Bravo EL; Carlson J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):480-6. PubMed ID: 3291284
    [No Abstract]   [Full Text] [Related]  

  • 46. Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats.
    Mitamura T; Yamada A; Ishida H; Fujihira S; Ohara K; Noguchi H; Mine Y
    J Toxicol Sci; 1994 Nov; 19(4):219-26. PubMed ID: 7533848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 48. Reduced nephrotoxicity of cyclosporine A after incorporation into liposomes.
    Smeesters C; Giroux L; Vinet B; Arnoux R; Chaland P; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):831-2. PubMed ID: 3388516
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity.
    McCormack AJ; Snipes RG; Dillon JJ; Yang JJ; Finn WF
    Ren Fail; 1990; 12(4):241-8. PubMed ID: 2100828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine A in high dosages induces renal interstitial fibrosis in the rat.
    Dieperink H; Kemp E; Starklint H
    Transplant Proc; 1988 Jun; 20(3):525-7. PubMed ID: 3381259
    [No Abstract]   [Full Text] [Related]  

  • 51. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity.
    Nambi P; Pullen M; Contino LC; Brooks DP
    Eur J Pharmacol; 1990 Oct; 187(1):113-6. PubMed ID: 2176978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic cyclosporine nephrotoxicity. A rodent model.
    Gillum DM; Truong L; Tasby J; Migliore P; Suki WN
    Transplantation; 1988 Aug; 46(2):285-92. PubMed ID: 3406978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine-induced hypertension in sheep. The role of thromboxanes.
    Tresham JJ; Whitworth JA; Scoggins BA; Bennett WM
    Transplantation; 1990 Jan; 49(1):144-8. PubMed ID: 2405549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevention of cyclosporine-associated nephrotoxicity by K-MAP.
    Teraoka S; Sanaka T; Sato H; Fuchinoue S; Honda H; Kawai T; Nakajima I; Tojinbara T; Fujita S; Funakoshi Y
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):179-82. PubMed ID: 3279608
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclosporine nephrotoxicity--experimental models.
    Thliveris JA; Yatscoff RW; Lukowski MP; Copeland KR
    Clin Biochem; 1991 Feb; 24(1):93-5. PubMed ID: 2060140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine induces glomerular hemodynamic changes in the rat.
    Bathe OF; Benediktsson H; Mandin H; Paul LC
    Transplantation; 1991 Mar; 51(3):739-41. PubMed ID: 2006537
    [No Abstract]   [Full Text] [Related]  

  • 58. Cyclosporine nephrotoxicity in conscious sheep.
    Friedman AL; Kahng KU; Monaco DO; Rosen BD; Wait RB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):595-602. PubMed ID: 3388503
    [No Abstract]   [Full Text] [Related]  

  • 59. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine.
    Dieterle A; Abeywickrama K; von Graffenried B
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):349-55. PubMed ID: 3381297
    [No Abstract]   [Full Text] [Related]  

  • 60. [Progressive factors of renal injury: exercise and blood pressure].
    Nihon Jinzo Gakkai Shi; 1989 May; 31(5):439-43. PubMed ID: 2622075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.